Evidence map›Paper›PMID 31013771›Full record

ArticleInternational journal of molecular sciences2019

Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure.

Maria Giovanna Francipane, Denis Bulanin, Eric Lagasse

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Maria Giovanna FrancipaneMcGowan Institute for Regenerative Medicine and Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA. francipa@pitt.edu.
Denis BulaninDepartment of Biomedical Sciences, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan. dbulanin@nu.edu.kz.
Eric LagasseMcGowan Institute for Regenerative Medicine and Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA. lagasse@pitt.edu.
McGowan Institute for Regenerative Medicine · USNazarbayev University · KZ

Funding

Nazarbayev University School of Medicine -Ri.MED Foundation -
6 · The paper itself

Abstract

5-Fluorouracil (5-FU) remains the gold standard of first-line treatment for colorectal cancer (CRC). Although it may initially debulk the tumor mass, relapses frequently occur, indicating the existence of cancer cells that are therapy-resistant and are capable of refueling tumor growth. To identify mechanisms of drug resistance, CRC stem-like cells were subjected to long-term 5-FU selection using either intermittent treatment regimen with the IC50 drug dose or continuous treatment regimen with escalating drug doses. Parental cancer cells were cultivated in parallel. Real-time PCR arrays and bioinformatic tools were used to investigate gene expression changes. We found the first method selected for cancer cells with more aggressive features. We therefore transplanted these cancer cells or parental cells in mice, and again, found that not only did the 5-FU-selected cancer cells generate more aggressive tumors with respect to their parental counterpart, but they also showed a different gene expression pattern as compared to what we had observed in vitro, with

Indexed as

Drug Resistance, NeoplasmAnimalsAntimetabolites, AntineoplasticApoptosisBiomarkersCell CycleCell Line, TumorColorectal NeoplasmsDisease Models, AnimalDNA DamageDose-Response Relationship, DrugFluorouracilGene Expression ProfilingHumansMiceModels, BiologicalAntimetabolites, AntineoplasticBiomarkersFluorouracilcancer stem cellschemoresistancecolorectal cancer

Identifiers

PMID31013771
PMCPMC6515384
OpenAlexW2938520987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.